CLEARPOINT NEURO INC. - COMMON STOCK

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

17 Oct 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Early Repayment of $10 Million Note

26 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Second Quarter 2024 Results

07 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

17 Jul 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

20 Jun 2024 05:45:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

01 Jun 2024 05:59:59 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports First Quarter 2024 Results

07 May 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore

02 May 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory

29 Apr 2024 05:00:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

24 Apr 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

23 Apr 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

16 Apr 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

19 Mar 2024 05:07:06 By Nasdaq GlobeNewswire

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

12 Mar 2024 13:05:00 By Nasdaq GlobeNewswire

Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System

11 Mar 2024 05:00:00 By Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

01 Mar 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

29 Feb 2024 05:00:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

28 Feb 2024 13:45:35 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

21 Feb 2024 13:05:00 By Nasdaq GlobeNewswire

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

24 Jan 2024 13:05:00 By Nasdaq GlobeNewswire